STAGE III RECTAL CANCER AJCC V7
Clinical trials for STAGE III RECTAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise against Hard-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested two different drug combinations in 240 people with advanced HER2-positive colorectal cancer that had spread and could not be removed by surgery. One group received the antibodies trastuzumab and pertuzumab, while the other received cetuximab (an antibod…
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could adding veliparib or pembrolizumab to standard therapy shrink rectal tumors better?
Disease control CompletedThis phase II trial tested whether adding veliparib or pembrolizumab to standard chemotherapy and radiation therapy helps shrink tumors in people with locally advanced rectal cancer. 363 participants received either standard treatment or one of the experimental combinations. The …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC